Ferrand Rashida A, Luethy Ruedi, Bwakura Filda, Mujuru Hilda, Miller Robert F, Corbett Elizabeth L
Mortimer Market Centre, Camden Primary Care Trust, London WC1E 6AU, UK.
Clin Infect Dis. 2007 Mar 15;44(6):874-8. doi: 10.1086/511873. Epub 2007 Feb 1.
Symptomatic human immunodeficiency virus (HIV) infection during late childhood and adolescence may be an emerging problem in southern Africa, but it is one that is poorly described. We investigated social and clinical features in patients of this age group presenting to a HIV treatment clinic with special adolescent services in Harare, Zimbabwe.
All patients aged 8-19 years and their guardians who attended an adolescent HIV treatment clinic were asked to consent to an interview and a review of medical notes.
Of 32 patients, 17 (53%) were male. The median CD4 cell count at presentation was 101 cells/microL (interquartile range, 35-197 cells/microL). Sixty-two percent experienced stunting (mean Z score for height-for-age, -2.55; 95% CI, -2.00 to -3.10), and all presented with World Health Organization stage 3 or 4 HIV infection. The median age at the first HIV test was 11 years, with a median of 3.5 years delay since the first HIV-related illness. Recurrent respiratory tract infections, skin complaints, diarrhea, and past tuberculosis were the most common HIV-related complaints. Seventeen patients (55%) were double orphans, and 10 (62%) surviving parents were known to be HIV positive.
In this small study, HIV-infected adolescents were profoundly immunosuppressed, with characteristics suggesting long-standing HIV infection. The equal sex distribution and high incidence of parental and sibling mortality were consistent; the majority of children had HIV-infected parents and, therefore, were potentially long-term survivors of HIV infection due to mother-to-child transmission. Greater recognition of the substantial burden of undiagnosed HIV infection and acquired immunodeficiency syndrome in this age group is needed, together with services aimed at reducing barriers to earlier diagnosis and initiation of treatment.
儿童晚期和青少年期出现症状的人类免疫缺陷病毒(HIV)感染在南部非洲可能是一个新出现的问题,但对此描述甚少。我们调查了在津巴布韦哈拉雷一家设有特殊青少年服务的HIV治疗诊所就诊的该年龄组患者的社会和临床特征。
所有8至19岁的患者及其监护人,若前往青少年HIV治疗诊所就诊,均被要求同意接受访谈并查阅病历。
32例患者中,17例(53%)为男性。就诊时CD4细胞计数中位数为101个/微升(四分位间距,35 - 197个/微升)。62%的患者发育迟缓(年龄别身高的平均Z评分,-2.55;95%置信区间,-2.00至-3.10),所有患者均表现为世界卫生组织3期或4期HIV感染。首次进行HIV检测的年龄中位数为11岁,自首次出现HIV相关疾病以来平均延迟3.5年。反复呼吸道感染、皮肤问题、腹泻和既往结核病是最常见的HIV相关症状。17例患者(55%)为双亲孤儿,已知10例(62%)在世父母为HIV阳性。
在这项小型研究中,HIV感染的青少年存在严重免疫抑制,其特征提示存在长期HIV感染。性别分布均衡以及父母和兄弟姐妹的高死亡率是一致的;大多数儿童的父母为HIV感染者,因此由于母婴传播,他们有可能成为HIV感染的长期幸存者。需要更加认识到该年龄组未诊断的HIV感染和获得性免疫缺陷综合征的沉重负担,同时需要提供旨在减少早期诊断和开始治疗障碍的服务。